SOPHiA GENETICS SA (NASDAQ:SOPH – Free Report) – Stock analysts at HC Wainwright decreased their FY2029 earnings per share (EPS) estimates for shares of SOPHiA GENETICS in a note issued to investors on Wednesday, August 5th. SOPHiA GENETICS Trading Down 7.9%SOPHiA GENETICS stock opened at $6.30 on Thursday. Key SOPHiA GENETICS NewsHere are the key news stories impacting SOPHiA GENETICS this week:Positive Sentiment: SOPHiA GENETICS raised its fiscal 2026 revenue outlook to $94 million–$96 million , above the roughly $93.4 million analyst consensus. Analyst price target updatesHC Wainwright raised its price target from $12 to $14 and BTIG Research increased its target from $8 to $9; both firms maintained Buy ratings. Featured ArticlesReceive News & Ratings for SOPHiA GENETICS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOPHiA GENETICS and related companies with MarketBeat.com's FREE daily email newsletter.